世界のモノクローナル抗体療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Monoclonal Antibody Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3909
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、モノクローナル抗体療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ヒトモノクローナル抗体、ヒト化モノクローナル抗体、キメラモノクローナル抗体、マウスモノクローナル抗体）、用途別市場規模（がん、自己免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・モノクローナル抗体療法の市場動向
・企業の競争状況、市場シェア
・モノクローナル抗体療法の種類別市場規模（ヒトモノクローナル抗体、ヒト化モノクローナル抗体、キメラモノクローナル抗体、マウスモノクローナル抗体）
・モノクローナル抗体療法の用途別市場規模（がん、自己免疫疾患、その他）
・モノクローナル抗体療法の北米市場規模2016-2027（アメリカ、カナダ）
・モノクローナル抗体療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・モノクローナル抗体療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・モノクローナル抗体療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・モノクローナル抗体療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbvie、Amgen、Glaxosmithkline、Merck、Novartis、Roche、Johson & Johson、Novartis）
・結論

Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages.
Therapeutic monoclonal antibodies act through multiple mechanisms, such as blocking of targeted molecule functions, inducing apoptosis in cells which express the target, or by modulating signaling pathways. One possible treatment for cancer involves monoclonal antibodies that bind only to cancer cell-specific antigens and induce an immune response against the target cancer cell.In addition, monoclonal antibodies used for autoimmune diseases include infliximab and adalimumab, which are effective in rheumatoid arthritis, Crohn’s disease, ulcerative colitis and ankylosing spondylitis by their ability to bind to and inhibit TNF-α.

Market Analysis and Insights: Global Monoclonal Antibody Therapy Market
The global Monoclonal Antibody Therapy market size is projected to reach US$ 178100 million by 2026, from US$ 109280 million in 2019, at a CAGR of 7.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Monoclonal Antibody Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Monoclonal Antibody Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Monoclonal Antibody Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Monoclonal Antibody Therapy market.

Global Monoclonal Antibody Therapy Scope and Market Size
Monoclonal Antibody Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibody Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Human Monoclonal Antibody
Humanized Monoclonal Antibody
Chimeric Monoclonal Antibody
Murine Monoclonal Antibody

Segment by Application
Cancer
Autoimmune Diseases
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbvie
Amgen
Glaxosmithkline
Merck
Novartis
Roche
Johson & Johson
Novartis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Human Monoclonal Antibody
1.2.3 Humanized Monoclonal Antibody
1.2.4 Chimeric Monoclonal Antibody
1.2.5 Murine Monoclonal Antibody
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Monoclonal Antibody Therapy Market Perspective (2016-2027)
2.2 Monoclonal Antibody Therapy Growth Trends by Regions
2.2.1 Monoclonal Antibody Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Monoclonal Antibody Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Monoclonal Antibody Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Monoclonal Antibody Therapy Industry Dynamic
2.3.1 Monoclonal Antibody Therapy Market Trends
2.3.2 Monoclonal Antibody Therapy Market Drivers
2.3.3 Monoclonal Antibody Therapy Market Challenges
2.3.4 Monoclonal Antibody Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Therapy Players by Revenue
3.1.1 Global Top Monoclonal Antibody Therapy Players by Revenue (2016-2021)
3.1.2 Global Monoclonal Antibody Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Monoclonal Antibody Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Therapy Revenue
3.4 Global Monoclonal Antibody Therapy Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapy Revenue in 2020
3.5 Monoclonal Antibody Therapy Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Therapy Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Monoclonal Antibody Therapy Breakdown Data by Type
4.1 Global Monoclonal Antibody Therapy Historic Market Size by Type (2016-2021)
4.2 Global Monoclonal Antibody Therapy Forecasted Market Size by Type (2022-2027)

5 Monoclonal Antibody Therapy Breakdown Data by Application
5.1 Global Monoclonal Antibody Therapy Historic Market Size by Application (2016-2021)
5.2 Global Monoclonal Antibody Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Monoclonal Antibody Therapy Market Size (2016-2027)
6.2 North America Monoclonal Antibody Therapy Market Size by Type
6.2.1 North America Monoclonal Antibody Therapy Market Size by Type (2016-2021)
6.2.2 North America Monoclonal Antibody Therapy Market Size by Type (2022-2027)
6.2.3 North America Monoclonal Antibody Therapy Market Size by Type (2016-2027)
6.3 North America Monoclonal Antibody Therapy Market Size by Application
6.3.1 North America Monoclonal Antibody Therapy Market Size by Application (2016-2021)
6.3.2 North America Monoclonal Antibody Therapy Market Size by Application (2022-2027)
6.3.3 North America Monoclonal Antibody Therapy Market Size by Application (2016-2027)
6.4 North America Monoclonal Antibody Therapy Market Size by Country
6.4.1 North America Monoclonal Antibody Therapy Market Size by Country (2016-2021)
6.4.2 North America Monoclonal Antibody Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Monoclonal Antibody Therapy Market Size (2016-2027)
7.2 Europe Monoclonal Antibody Therapy Market Size by Type
7.2.1 Europe Monoclonal Antibody Therapy Market Size by Type (2016-2021)
7.2.2 Europe Monoclonal Antibody Therapy Market Size by Type (2022-2027)
7.2.3 Europe Monoclonal Antibody Therapy Market Size by Type (2016-2027)
7.3 Europe Monoclonal Antibody Therapy Market Size by Application
7.3.1 Europe Monoclonal Antibody Therapy Market Size by Application (2016-2021)
7.3.2 Europe Monoclonal Antibody Therapy Market Size by Application (2022-2027)
7.3.3 Europe Monoclonal Antibody Therapy Market Size by Application (2016-2027)
7.4 Europe Monoclonal Antibody Therapy Market Size by Country
7.4.1 Europe Monoclonal Antibody Therapy Market Size by Country (2016-2021)
7.4.2 Europe Monoclonal Antibody Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Therapy Market Size (2016-2027)
8.2 Asia-Pacific Monoclonal Antibody Therapy Market Size by Type
8.2.1 Asia-Pacific Monoclonal Antibody Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Monoclonal Antibody Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Monoclonal Antibody Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Monoclonal Antibody Therapy Market Size by Application
8.3.1 Asia-Pacific Monoclonal Antibody Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Monoclonal Antibody Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Monoclonal Antibody Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Monoclonal Antibody Therapy Market Size by Region
8.4.1 Asia-Pacific Monoclonal Antibody Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Monoclonal Antibody Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Monoclonal Antibody Therapy Market Size (2016-2027)
9.2 Latin America Monoclonal Antibody Therapy Market Size by Type
9.2.1 Latin America Monoclonal Antibody Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Monoclonal Antibody Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Monoclonal Antibody Therapy Market Size by Type (2016-2027)
9.3 Latin America Monoclonal Antibody Therapy Market Size by Application
9.3.1 Latin America Monoclonal Antibody Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Monoclonal Antibody Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Monoclonal Antibody Therapy Market Size by Application (2016-2027)
9.4 Latin America Monoclonal Antibody Therapy Market Size by Country
9.4.1 Latin America Monoclonal Antibody Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Monoclonal Antibody Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Therapy Market Size (2016-2027)
10.2 Middle East & Africa Monoclonal Antibody Therapy Market Size by Type
10.2.1 Middle East & Africa Monoclonal Antibody Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Monoclonal Antibody Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Monoclonal Antibody Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Monoclonal Antibody Therapy Market Size by Application
10.3.1 Middle East & Africa Monoclonal Antibody Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Monoclonal Antibody Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Monoclonal Antibody Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Monoclonal Antibody Therapy Market Size by Country
10.4.1 Middle East & Africa Monoclonal Antibody Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Monoclonal Antibody Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Monoclonal Antibody Therapy Introduction
11.1.4 Abbvie Revenue in Monoclonal Antibody Therapy Business (2016-2021)
11.1.5 Abbvie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Monoclonal Antibody Therapy Introduction
11.2.4 Amgen Revenue in Monoclonal Antibody Therapy Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Glaxosmithkline
11.3.1 Glaxosmithkline Company Details
11.3.2 Glaxosmithkline Business Overview
11.3.3 Glaxosmithkline Monoclonal Antibody Therapy Introduction
11.3.4 Glaxosmithkline Revenue in Monoclonal Antibody Therapy Business (2016-2021)
11.3.5 Glaxosmithkline Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Monoclonal Antibody Therapy Introduction
11.4.4 Merck Revenue in Monoclonal Antibody Therapy Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Monoclonal Antibody Therapy Introduction
11.5.4 Novartis Revenue in Monoclonal Antibody Therapy Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Monoclonal Antibody Therapy Introduction
11.6.4 Roche Revenue in Monoclonal Antibody Therapy Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Johson & Johson
11.7.1 Johson & Johson Company Details
11.7.2 Johson & Johson Business Overview
11.7.3 Johson & Johson Monoclonal Antibody Therapy Introduction
11.7.4 Johson & Johson Revenue in Monoclonal Antibody Therapy Business (2016-2021)
11.7.5 Johson & Johson Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Monoclonal Antibody Therapy Introduction
11.8.4 Novartis Revenue in Monoclonal Antibody Therapy Business (2016-2021)
11.8.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Monoclonal Antibody Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Human Monoclonal Antibody
Table 3. Key Players of Humanized Monoclonal Antibody
Table 4. Key Players of Chimeric Monoclonal Antibody
Table 5. Key Players of Murine Monoclonal Antibody
Table 6. Global Monoclonal Antibody Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Monoclonal Antibody Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Monoclonal Antibody Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Monoclonal Antibody Therapy Market Share by Regions (2016-2021)
Table 10. Global Monoclonal Antibody Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Monoclonal Antibody Therapy Market Share by Regions (2022-2027)
Table 12. Monoclonal Antibody Therapy Market Trends
Table 13. Monoclonal Antibody Therapy Market Drivers
Table 14. Monoclonal Antibody Therapy Market Challenges
Table 15. Monoclonal Antibody Therapy Market Restraints
Table 16. Global Monoclonal Antibody Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Monoclonal Antibody Therapy Market Share by Players (2016-2021)
Table 18. Global Top Monoclonal Antibody Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapy as of 2020)
Table 19. Ranking of Global Top Monoclonal Antibody Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Monoclonal Antibody Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Monoclonal Antibody Therapy Product Solution and Service
Table 23. Date of Enter into Monoclonal Antibody Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Monoclonal Antibody Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Monoclonal Antibody Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Monoclonal Antibody Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Monoclonal Antibody Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Monoclonal Antibody Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Monoclonal Antibody Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Monoclonal Antibody Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Monoclonal Antibody Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Monoclonal Antibody Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Monoclonal Antibody Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Monoclonal Antibody Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Monoclonal Antibody Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Monoclonal Antibody Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Monoclonal Antibody Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Monoclonal Antibody Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Monoclonal Antibody Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Monoclonal Antibody Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Monoclonal Antibody Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Monoclonal Antibody Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Monoclonal Antibody Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Monoclonal Antibody Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Monoclonal Antibody Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Monoclonal Antibody Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Monoclonal Antibody Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Monoclonal Antibody Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Monoclonal Antibody Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Monoclonal Antibody Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Monoclonal Antibody Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Monoclonal Antibody Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Monoclonal Antibody Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Monoclonal Antibody Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Monoclonal Antibody Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Monoclonal Antibody Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Monoclonal Antibody Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Monoclonal Antibody Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Monoclonal Antibody Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Monoclonal Antibody Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Monoclonal Antibody Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbvie Company Details
Table 64. Abbvie Business Overview
Table 65. Abbvie Monoclonal Antibody Therapy Product
Table 66. Abbvie Revenue in Monoclonal Antibody Therapy Business (2016-2021) & (US$ Million)
Table 67. Abbvie Recent Development
Table 68. Amgen Company Details
Table 69. Amgen Business Overview
Table 70. Amgen Monoclonal Antibody Therapy Product
Table 71. Amgen Revenue in Monoclonal Antibody Therapy Business (2016-2021) & (US$ Million)
Table 72. Amgen Recent Development
Table 73. Glaxosmithkline Company Details
Table 74. Glaxosmithkline Business Overview
Table 75. Glaxosmithkline Monoclonal Antibody Therapy Product
Table 76. Glaxosmithkline Revenue in Monoclonal Antibody Therapy Business (2016-2021) & (US$ Million)
Table 77. Glaxosmithkline Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Monoclonal Antibody Therapy Product
Table 81. Merck Revenue in Monoclonal Antibody Therapy Business (2016-2021) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Monoclonal Antibody Therapy Product
Table 86. Novartis Revenue in Monoclonal Antibody Therapy Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Monoclonal Antibody Therapy Product
Table 91. Roche Revenue in Monoclonal Antibody Therapy Business (2016-2021) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Johson & Johson Company Details
Table 94. Johson & Johson Business Overview
Table 95. Johson & Johson Monoclonal Antibody Therapy Product
Table 96. Johson & Johson Revenue in Monoclonal Antibody Therapy Business (2016-2021) & (US$ Million)
Table 97. Johson & Johson Recent Development
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Revenue in Monoclonal Antibody Therapy Business (2016-2021) & (US$ Million)
Table 101. Novartis Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Therapy Market Share by Type: 2020 VS 2027
Figure 2. Human Monoclonal Antibody Features
Figure 3. Humanized Monoclonal Antibody Features
Figure 4. Chimeric Monoclonal Antibody Features
Figure 5. Murine Monoclonal Antibody Features
Figure 6. Global Monoclonal Antibody Therapy Market Share by Application: 2020 VS 2027
Figure 7. Cancer Case Studies
Figure 8. Autoimmune Diseases Case Studies
Figure 9. Others Case Studies
Figure 10. Monoclonal Antibody Therapy Report Years Considered
Figure 11. Global Monoclonal Antibody Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Monoclonal Antibody Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Monoclonal Antibody Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Monoclonal Antibody Therapy Market Share by Regions (2022-2027)
Figure 15. Global Monoclonal Antibody Therapy Market Share by Players in 2020
Figure 16. Global Top Monoclonal Antibody Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapy Revenue in 2020
Figure 18. Global Monoclonal Antibody Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Monoclonal Antibody Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Monoclonal Antibody Therapy Market Share by Type (2016-2027)
Figure 22. North America Monoclonal Antibody Therapy Market Share by Application (2016-2027)
Figure 23. North America Monoclonal Antibody Therapy Market Share by Country (2016-2027)
Figure 24. United States Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Monoclonal Antibody Therapy Market Share by Type (2016-2027)
Figure 28. Europe Monoclonal Antibody Therapy Market Share by Application (2016-2027)
Figure 29. Europe Monoclonal Antibody Therapy Market Share by Country (2016-2027)
Figure 30. Germany Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Monoclonal Antibody Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Monoclonal Antibody Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Monoclonal Antibody Therapy Market Share by Region (2016-2027)
Figure 40. China Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Monoclonal Antibody Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Monoclonal Antibody Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Monoclonal Antibody Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Monoclonal Antibody Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Monoclonal Antibody Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Monoclonal Antibody Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Monoclonal Antibody Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbvie Revenue Growth Rate in Monoclonal Antibody Therapy Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Monoclonal Antibody Therapy Business (2016-2021)
Figure 61. Glaxosmithkline Revenue Growth Rate in Monoclonal Antibody Therapy Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Monoclonal Antibody Therapy Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Monoclonal Antibody Therapy Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Monoclonal Antibody Therapy Business (2016-2021)
Figure 65. Johson & Johson Revenue Growth Rate in Monoclonal Antibody Therapy Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Monoclonal Antibody Therapy Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界のモノクローナル抗体治療市場規模・現状・予測（2021年-2027年）

Global Monoclonal Antibody Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3910 2021年4月 95Pages
QYResearch社発行の本調査資料では、モノクローナル抗体治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（がん、自己免疫疾患、感染症、造血系疾患、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、...

世界のモノクローナル抗体製品市場規模・現状・予測（2021年-2027年）

Global Monoclonal Antibody Based Products Market Size, Status and Forecast 2021-2027
QYR2104Z3905 2021年4月 90Pages
QYResearch社発行の本調査資料では、モノクローナル抗体製品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（がん、自己免疫、炎症性、感染性、微生物性、ウイルス性疾患）、用途別市場規模（病院、研究、学術機関、診療所、診断研究所）、主要地域別...

世界のモノクローナル抗体作製サービス市場規模・現状・予測（2021年-2027年）

Global Monoclonal Antibody Custom Service Market Size, Status and Forecast 2021-2027
QYR2104Z3906 2021年4月 90Pages
QYResearch社発行の本調査資料では、モノクローナル抗体作製サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ラットカスタムモノクローナル抗体、ウサギカスタムモノクローナル抗体、その他）、用途別市場規模（病院、研究所、製薬・バイオテ...

世界のモノクローナル抗体サービス市場規模・現状・予測（2021年-2027年）

Global Monoclonal Antibody Service Market Size, Status and Forecast 2021-2027
QYR2104Z3907 2021年4月 134Pages
QYResearch社発行の本調査資料では、モノクローナル抗体サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（試薬、医薬品、その他）、用途別市場規模（診断研究所、研究・学術研究所、製薬・バイオテクノロジー企業）、主要地域別市場規模（北米...

世界のモノクローナル抗体サービス市場規模・現状・予測（2021年-2027年）

世界のモノクローナル抗体治療市場規模・現状・予測（2021年-2027年）

Global Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3908 2021年4月 97Pages
QYResearch社発行の本調査資料では、モノクローナル抗体治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ヒト化抗体、ヒトマウスキメラ抗体）、用途別市場規模（がん、自己免疫疾患、感染症、造血系疾患、眼科疾患、その他）、主要地域別市場規模...

世界のモノクローナルマウス抗体市場規模・現状・予測（2021年-2027年）

Global Monoclonal Mouse Antibody Market Size, Status and Forecast 2021-2027
QYR2104Z3911 2021年4月 129Pages
QYResearch社発行の本調査資料では、モノクローナルマウス抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（IgM、IgG、IgA、その他）、用途別市場規模（治療、研究、診断）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のモノクローナルマウス抗体市場規模・現状・予測（2021年-2027年）

世界の併用抗体療法市場規模・現状・予測（2021年-2027年）

Global Combination Antibody Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1458 2021年4月 90Pages
QYResearch社発行の本調査資料では、併用抗体療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法/抗体、抗体/抗体、結合抗体、二重特異性抗体）、用途別市場規模（病院、がん研究所、クリニック、ASC）、主要地域別市場規模（北米、ア...

世界のモノクローナル抗体治療市場 2021：企業別、地域別、種類・用途別

Global Monoclonal Antibody Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z09556 2021年4月 104Pages
当調査資料では、モノクローナル抗体治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。モノクローナル抗体治療の種類別市場規模（がん、自己免疫疾患、感染症、造血系疾患、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨー...

世界のモノクローナル抗体治療市場規模・現状・予測（2021年-2027年） For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body. …
世界のモノクローナル抗体治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Monoclonal Antibody Therapeutics Market The global Monoclonal Antibody Therapeutics market size is projected to reach US$ 178100 million by 2026, from US$ 109280 million in 2019, at a CAGR of 7.1% during 2021-2026. With industry-standard accuracy in analysis and …
世界のモノクローナル抗体製品市場規模・現状・予測（2021年-2027年） Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins. This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodie…
世界のモノクローナル抗体治療市場 2021：企業別、地域別、種類・用途別 The Monoclonal Antibody Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
世界のモノクローナル抗体作製サービス市場規模・現状・予測（2021年-2027年） Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…